ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Flubendazole, FDA-approved anthelmintic, elicits valid antitumor effects by targeting P53 and promoting ferroptosis in castration-resistant prostate cancer

Zhou, Xumin; Zou, Libin; Chen, Wenbin; Yang, Taowei; Luo, Junqi; Wu, Kaihui; Shu, Fangpeng; Tan, Xiao; Yang, Yu; Cen, Shengren; Li, Chuanyin*; Mao, Xiangming*广州医学院; 北京大学; 南方医科大学; 1
Pharmacological Research2021-2DOI: 10.1016/j.phrs.2020.105305
41被引7阅读
引用收藏
分享

摘要

On account of incurable castration-resistant prostate cancer (CRPC) inevitably developing after treating with androgen deprivation therapy, it is an urgent need to find new therapeutic strategies. Flubendazole is a well-known anti-malarial drug that is recently reported to be a potential anti-tumor agent in various types of human cancer cells. However, whether flubendazole could inhibit the castration-resistant prostate cancer has not been well charified. Thus, the aim of the present study was to characterize the precise mechanism of action of flubendazole on the CRPC. In this study, we investigated the potential effect of flubendazole on cell proliferation, cell cycle and cell death in CRPC cells (PC3 and DU145). We found that flubendazole inhibited cell proliferation, caused cell cycle arrest in G2/M phase and promoted cell death in vitro, and suppressed growth of CRPC tumor in xenograft models. In addition, we reported that flubendazole induced the expression of P53, which partly accounted for the G2/M phase arrest and led to inhibition of the transcription of SLC7A11, and then down-regulated the GPX4, which is a major ferroptosis-related gene. Furthermore, flubendazole exhibited synergistic effect with 5-fluorouracil (5-Fu) in chemotherapy of CRPC. This study provides biological evidence that flubendazole is a novel P53 inducer which exerts anti-proliferation and pro-apoptosis effects in CRPC through hindering the cell cycle and activating the ferroptosis, and indicates that a novel utilization of flubendazole in neoadjuvant chemotherapy of CRPC.

学科与关键词

关键词
FlubendazoleCastration-resistant prostate cancer (CRPC)P53FerroptosisAnti-tumor
相关
加载中…
  • Inhibition of phosphoglycerate dehydrogenase induces ferroptosis and overcomes enzalutamide resistance in castration-resistant prostate cancer cells
    Wang, Jinxiang; Zeng, Leli; Wu, Nisha; Liang, Yanling; Jin, Jie; Fan, Mingming; Lai, Xiaoju; Chen, Zhe-Sheng; Pan, Yihang*; Zeng, Fangyin*; Deng, Fan*DRUG RESISTANCE UPDATES, 2023, 70: 100985.被引 2
  • Catalase Inhibitors with Dual Pro-Oxidant Effect as New Therapeutic Agents in Castration-Resistant Prostate Cancer
    Chen, Yuan-Yuan; Liang, Hao-Qi; Liu, Meng-Ting; Huang, Wei; Yi, Peng-Fei; Yuan, Si-Qi; Mei, Long-Can; Hu, Ying-Hui; Cao, Ya-Ya; Hao, Ge-Fei; Zhang, Dan*; Yang, Guang-Fu*ADVANCED THERAPEUTICS, 2021, 4(3): 2000164.被引 1
  • Luteolin induces ferroptosis in prostate cancer cells by promoting TFEB nuclear translocation and increasing ferritinophagy
    Fu, Wei; Xu, Lei; Chen, Yingwen; Zhang, Zezheng; Chen, Shuchao; Li, Qixin*; You, Xujun*PROSTATE, 2024, 84(3): 223-236.
查看全部 →

发表信息

论文状态
公开发表
期刊
Pharmacological Research
发表日期
2021-02
卷期
第 164 卷
页码
105305
DOI
10.1016/j.phrs.2020.105305
语言
ENGLISH
期刊收录
NSL
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81773277]; Science and Technology Program of Guangzhou, China [201803010014]

作者

  • Z

    Zhou, Xumin (第一作者)

    southern med univ

  • Z

    Zou, Libin

    southern med univ

查看全部 12 位作者收起作者
  • C

    Chen, Wenbin

    southern med univ

  • Y

    Yang, Taowei

    southern med univ

  • L

    Luo, Junqi

    southern med univ

  • W

    Wu, Kaihui

    southern med univ

  • S

    Shu, Fangpeng

    guangzhou med univ · guangzhou women & childrens med ctr

  • T

    Tan, Xiao

    1

  • Y

    Yang, Yu

    peking univ

  • C

    Cen, Shengren

    southern med univ

  • L

    Li, Chuanyin (通讯)

    southern med univ

  • M

    Mao, Xiangming (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417